Build status - In Progress
Transseptal vs. Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli Multi-center comparative effectiveness randomized clinical trial to assess a transeptal approach to left ventricular ablation compared to a retrograd aortic aproach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tacht=ycardia (VT) and /or premature ventricular contractions (PVCs)
Recruiting
99 years or below
All
12 participants needed
1 Location
Brief description of study
Both transseptal and retrograde aortic approaches are routinely utilized in pediatric and adult cardiac electrophysiology and cardiac catheterization laboratories in the United States and have been in clinical practice for decades to treat multiple types of left atrial and ventricular arrhythmias. As either approach can be used to perform catheter ablation of ventricular tachycardia (VT) and premature ventricular contractions (PVCs), the decision is currently based on physician preference driven primarily by anecdote and personal experience.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
14 Oct 2020.
Study ID: 834089
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or